53rd conference synthesis and analysis of drugs 2025 - Book of Abstracts

Significance of topic

In analytical chemistry, reliable synthesis and analysis of drug compounds are critical for drug discovery, quality control, and regulatory compliance. Conferences like the 53rd Conference on Synthesis and Analysis of Drugs provide a multidisciplinary forum for researchers and industry professionals to share innovations in synthetic methods, chromatographic techniques, mass spectrometry, biocatalysis, and advanced imaging. This exchange accelerates the development of safer, more effective pharmaceuticals.

Objectives and overview of the conference

• Present latest research from academic and industrial laboratories on drug synthesis, design, and analysis.
• Foster collaboration between medicinal chemists, analytical chemists, pharmacologists, and regulatory experts.
• Showcase advances in analytical methodologies, automation, and green chemistry.
• Provide a platform for young scientists through short talks, posters, and awards.

Conference Program Highlights

• Invited lectures on elemental labeling in ICP-MS, sustainable flow peptide synthesis, biocatalytic routes to natural products, and selective boron functionalization.
• Plenary talks covering supercritical fluid chromatography, pharma park development, quinolone synthesis, and novel ribosome inhibitors.
• Short talks on carbonic anhydrase inhibitors, natural product extraction, drug design, analytical methods such as LA-ICP-MS and ROA, and new synthetic scaffolds.
• Poster sessions presenting over 100 contributions on antimicrobial agents, glycan analysis, chiral separations, drug delivery, and environmental contaminant monitoring.
• Industrial and sponsor talks demonstrating cutting-edge instruments and digital solutions for pharmaceutical R&D and QA/QC.

Key trends and practical applications

• Integration of advanced separation techniques and high-resolution imaging to characterize complex drug formulations.
• Automation and digital platforms enabling rapid method development, data analysis, and regulatory compliance.
• Green chemistry approaches in synthesis and sample preparation to reduce waste and environmental impact.
• Emerging bioanalytical tools such as single-cell metal mapping, continuous-flow peptide synthesis, and evanescent field sensors.

Future trends and possibilities

Continuing developments in AI-driven retrosynthesis, microfluidic reactors, and multi-modal imaging promise further increases in throughput and selectivity. Collaboration with industry will accelerate translation of laboratory methods into scalable processes and on-chip devices. The next conference in Bratislava will build on these themes to address challenges in emerging therapeutics and precision medicine.

Conclusion

The 53rd Conference on Synthesis and Analysis of Drugs presented a rich picture of current advances and fostered collaborations across academia and industry. Rapid innovations in analytical chemistry and synthetic methodology are key to meeting growing demands for novel pharmaceuticals, improved drug safety, and sustainable production.